• Antibody-drug conjugates
• Targeting platform – 'OptiLink'
• Light activated cancer therapy – 'ProstaLite'
• MRI contrast agents & imaging
• Photosensitiser innovations
• Additional products and applications

• Investment History & Strategy
• Partnering opportunities

• Press Releases
• News Items
• Scientific Publications

• Background
• Achievements
• The Team
• Sitemap

PhotoBiotics Scientific Publications

1. Novel photosensitisers derived from pyropheophorbide-a: uptake by cells and
   photodynamic efficiency in vitro
   PDF Document (0.5Mb)
   
   
2. Fluorescence characterisation of multiply-loaded anti-HER2 single chain
   Fv-photosesitizer conjugates suitable for photodynamic therapy
   PDF Document (0.2Mb)
   
   
3. Targeted photodynamic therapy with multiply-loaded recombinant antibody fragments
   PDF Document (0.5Mb)
   
   
4. Towards recombinant antibodyfragment targeted photodynamic therapy
   PDF Document (1.85Mb)